{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:53:51Z","timestamp":1793159631283,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cannabinoid-based therapy has been shown to be promising and is emerging as crucial for the treatment of cognitive deficits, mental illnesses, and many diseases considered incurable. There is a need to find an appropriate therapy for Alzheimer\u2019s disease, and cannabinoid-based therapy appears to be a feasible possibility.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>This report addresses the beneficial effect of cannabinoids in microdoses on improving memory and brain functions of a patient with mild-stage Alzheimer\u2019s disease. The patient is a 75-year-old white man presenting with main symptoms of memory deficit, spatial and temporal disorientation, and limited daily activity. The experimental therapeutic intervention was carried out for 22\u00a0months with microdoses of a cannabis extract containing cannabinoids. Clinical evaluations using Mini-Mental State Examination and Alzheimer\u2019s Disease Assessment Scale-Cognitive Subscale were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Here we provide original evidence that cannabinoid microdosing could be effective as an Alzheimer\u2019s disease treatment while preventing major side effects. This is an important step toward dissociating cannabinoids\u2019 health-improving effects from potential narcotic-related limitations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03457-w","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T18:03:06Z","timestamp":1657648986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer\u2019s disease symptoms: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Ana Carolina","family":"Ruver-Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00edra Assun\u00e7\u00e3o","family":"Bicca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano Soares","family":"de Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Helena Lameiro","family":"de Noronha Sales Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabr\u00edcio Alano","family":"Pamplona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elton Gomes","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-4045","authenticated-orcid":false,"given":"Francisney Pinto","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"key":"3457_CR1","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association. Alzheimer\u2019s Disease: facts and figures. Alzheimers Dement. 2018;14(3):367\u2013429.","DOI":"10.1016\/j.jalz.2018.02.001"},{"issue":"1","key":"3457_CR2","first-page":"16","volume":"6","author":"RS Pinto","year":"2015","unstructured":"Pinto RS, et\u00a0al. Doen\u00e7a de Alzheimer: Abordagem farmacoterap\u00eautica. Bol Inf Geum. 2015;6(1):16\u201325.","journal-title":"Bol Inf Geum"},{"issue":"7266","key":"3457_CR3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/461895a","volume":"461","author":"L Mucke","year":"2009","unstructured":"Mucke L. Alzheimer\u2019s disease. Nature. 2009;461(7266):895\u20137.","journal-title":"Nature"},{"issue":"s1","key":"3457_CR4","doi-asserted-by":"publisher","first-page":"S567","DOI":"10.3233\/JAD-179941","volume":"64","author":"EN Cline","year":"2018","unstructured":"Cline EN, et\u00a0al. The amyloid-\u03b2 oligomer hypothesis: beginning of the third decade. J Alzheimer\u2019s Dis. 2018;64(s1):S567-610.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"1","key":"3457_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","volume":"89","author":"T Iuvone","year":"2004","unstructured":"Iuvone T, et\u00a0al. Neuroprotective effect of cannabidiol, a non-psychoactive component from cannabis sativa, on \u03b2-amyloid-induced toxicity in PC12 cells. J Neurochem. 2004;89(1):134\u201341.","journal-title":"J Neurochem"},{"issue":"3","key":"3457_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0306-4522(94)90511-8","volume":"63","author":"TM Westlake","year":"1994","unstructured":"Westlake TM, et\u00a0al. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer\u2019s brains. Neuroscience. 1994;63(3):637\u201352.","journal-title":"Neuroscience"},{"issue":"4","key":"3457_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/syn.20050","volume":"53","author":"E N\u00fa\u00f1ez","year":"2004","unstructured":"N\u00fa\u00f1ez E, et\u00a0al. Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse. 2004;53(4):208\u201313.","journal-title":"Synapse"},{"key":"3457_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnint.2018.00051","volume":"12","author":"EB Russo","year":"2018","unstructured":"Russo EB. Cannabis therapeutics and the future of neurology. Front Integr Neurosci. 2018;12:1\u201311.","journal-title":"Front Integr Neurosci"},{"key":"3457_CR9","doi-asserted-by":"crossref","unstructured":"Ronan PJ et\u00a0al. Molecular mechanisms of cannabis signaling in the brain. In: Progress in molecular biology and translational science. United States: Elsevier Inc.; 2016. p. 123\u201347.","DOI":"10.1016\/bs.pmbts.2015.10.002"},{"issue":"6","key":"3457_CR10","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/nm.4311","volume":"23","author":"A Bilkei-Gorzo","year":"2017","unstructured":"Bilkei-Gorzo A, et\u00a0al. A chronic low dose of \u03949-tetrahydrocannabinol (THC) restores cognitive function in old mice. Nat Med. 2017;23(6):782\u20137.","journal-title":"Nat Med"},{"key":"3457_CR11","unstructured":"Abramovici H. Information for Health Care Professionals: Cannabis (marihuana, marijuana) and the cannabinoids. Canada: Health Canada; 2013. 152 p."},{"issue":"20","key":"3457_CR12","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","volume":"172","author":"RB Laprairie","year":"2015","unstructured":"Laprairie RB, et\u00a0al. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015;172(20):4790\u2013805.","journal-title":"Br J Pharmacol"},{"issue":"Oct","key":"3457_CR13","first-page":"1","volume":"8","author":"E Mart\u00ednez-Pinilla","year":"2017","unstructured":"Mart\u00ednez-Pinilla E, et\u00a0al. Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors. Front Pharmacol. 2017;8(Oct):1\u201310.","journal-title":"Front Pharmacol"},{"issue":"2","key":"3457_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","volume":"66","author":"E Russo","year":"2006","unstructured":"Russo E, Guy GW. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses. 2006;66(2):234\u201346.","journal-title":"Med Hypotheses"},{"issue":"3","key":"3457_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, B\u00e1tkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389\u2013462.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"3457_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/gps.1828","volume":"23","author":"MJ Passmore","year":"2008","unstructured":"Passmore MJ. The cannabinoid receptor agonist nabilone for the treatment of dementia-related agitation. Int J Geriat Psychiatry. 2008;23(1):116.","journal-title":"Int J Geriat Psychiatry."},{"key":"3457_CR17","doi-asserted-by":"crossref","unstructured":"Kuharic DB et\u00a0al. Cannabinoids for the treatment of dementia. Cochrane Database Syst Rev. 2021(9).","DOI":"10.1002\/14651858.CD012820.pub2"},{"key":"3457_CR18","first-page":"1","volume-title":"American herbal pharmacopoeia","author":"J Marcu","year":"2013","unstructured":"Marcu J, Swisher D. Cannabis Inflorescence (Cannabis spp.). In: Upton R, Craker L, ElSohly M, Romm A, Russo E, Sexton M, editors. American herbal pharmacopoeia. Canada: American Herbal Pharmacopoeia; 2013. p. 1\u201364."},{"issue":"1","key":"3457_CR19","doi-asserted-by":"publisher","first-page":"01","DOI":"10.1590\/S0004-282X1994000100001","volume":"52","author":"PHF Bertolucci","year":"1994","unstructured":"Bertolucci PHF, et\u00a0al. O mini-exame do estado mental em uma popula\u00e7\u00e3o geral: impacto da escolaridade. Arq Neuropsiquiatr. 1994;52(1):01\u20137.","journal-title":"Arq Neuropsiquiatr"},{"issue":"11","key":"3457_CR20","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","volume":"141","author":"WG Rosen","year":"1984","unstructured":"Rosen WG, et\u00a0al. A new rating scale for Alzheimer\u2019s disease. Am J Psychiatry. 1984;141(11):1356\u201364.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"3457_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40265-017-0720-6","volume":"77","author":"GM Keating","year":"2017","unstructured":"Keating GM. Delta-9-tetrahydrocannabinol\/cannabidiol oromucosal spray (Sativex\u00ae): a review in multiple sclerosis-related spasticity. Drugs. 2017;77(5):563\u201374.","journal-title":"Drugs"},{"key":"3457_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.drugalcdep.2017.03.030","volume":"177","author":"E Childs","year":"2017","unstructured":"Childs E, Lutz JA, De Wit H. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Drug Alcohol Depend. 2017;177:136\u201344.","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"3457_CR23","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1038\/npp.2012.123","volume":"37","author":"AA Rey","year":"2012","unstructured":"Rey AA, et\u00a0al. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA B receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacology. 2012;37(12):2624\u201334.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"3457_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","volume":"81","author":"MP Viveros","year":"2005","unstructured":"Viveros MP, Marco EM, File SE. Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav. 2005;81(2):331\u201342.","journal-title":"Pharmacol Biochem Behav"},{"issue":"10","key":"3457_CR25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1177\/0269881112446530","volume":"26","author":"ME Ballard","year":"2012","unstructured":"Ballard ME, Bedi G, De Wit H. Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images. J Psychopharmacol. 2012;26(10):1289\u201398.","journal-title":"J Psychopharmacol"},{"issue":"4","key":"3457_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123289","volume":"10","author":"S Matsunaga","year":"2015","unstructured":"Matsunaga S, Kishi T, Iwata N. Memantine monotherapy for Alzheimer\u2019s disease: a systematic review and meta-analysis. PLoS ONE. 2015;10(4): e0123289.","journal-title":"PLoS ONE"},{"issue":"10","key":"3457_CR27","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1080\/14740338.2018.1524870","volume":"17","author":"S Matsunaga","year":"2018","unstructured":"Matsunaga S, et\u00a0al. The efficacy and safety of memantine for the treatment of Alzheimer\u2019s disease. Expert Opin Drug Saf. 2018;17(10):1053\u201361.","journal-title":"Expert Opin Drug Saf"},{"issue":"23","key":"3457_CR28","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1212\/WNL.0000000000001675","volume":"84","author":"GAH Van Den Elsen","year":"2015","unstructured":"Van Den Elsen GAH, et\u00a0al. Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: a randomized controlled trial. Neurology. 2015;84(23):2338\u201346.","journal-title":"Neurology"},{"issue":"11","key":"3457_CR29","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jagp.2019.05.002","volume":"27","author":"N Herrmann","year":"2019","unstructured":"Herrmann N, et\u00a0al. Randomized placebo-controlled trial of nabilone for agitation in Alzheimer\u2019s disease. Am J Geriatr Psychiatry. 2019;27(11):1161\u201373.","journal-title":"Am J Geriatr Psychiatry"},{"key":"3457_CR30","doi-asserted-by":"crossref","unstructured":"Guy GW, Stott CG. The development of Sativex\u00ae\u2014a natural cannabis-based medicine. Cannabinoids as Therapeutics. 2005;231\u201363.","DOI":"10.1007\/3-7643-7358-X_14"},{"issue":"8","key":"3457_CR31","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s40263-015-0270-y","volume":"29","author":"CS Liu","year":"2015","unstructured":"Liu CS, et\u00a0al. Cannabinoids for the treatment of agitation and aggression in Alzheimer\u2019s disease. CNS Drugs. 2015;29(8):615\u201323.","journal-title":"CNS Drugs"},{"issue":"5","key":"3457_CR32","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/sj.bjp.0707446","volume":"152","author":"VA Campbell","year":"2007","unstructured":"Campbell VA, Gowran A. Alzheimer\u2019s disease; taking the edge off with cannabinoids? Br J Pharmacol. 2007;152(5):655\u201362.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"3457_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/can.2017.0036","volume":"2","author":"P Morales","year":"2017","unstructured":"Morales P, Reggio PH. An update on non-CB1, non-CB2 cannabinoid related G-protein-coupled receptors. Cannabis Cannabinoid Res. 2017;2(1):265\u201373.","journal-title":"Cannabis Cannabinoid Res"},{"key":"3457_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-9-8","volume":"9","author":"AM Mart\u00edn-Moreno","year":"2012","unstructured":"Mart\u00edn-Moreno AM, et\u00a0al. Prolonged oral cannabinoid administration prevents neuroinflammation, lowers \u03b2-amyloid levels and improves cognitive performance in Tg APP 2576 mice. J Neuroinflammation. 2012;9:1\u201315.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"3457_CR35","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3233\/JAD-140093","volume":"42","author":"C Cao","year":"2014","unstructured":"Cao C, et\u00a0al. The potential therapeutic effects of THC on Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2014;42(3):973\u201384.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"3457_CR36","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1098\/rstb.2011.0388","volume":"367","author":"A Bilkei-Gorzo","year":"2012","unstructured":"Bilkei-Gorzo A. The endocannabinoid system in normal and pathological brain ageing. Philos Trans R Soc B Biol Sci. 2012;367:3326\u201341.","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"3457_CR37","doi-asserted-by":"publisher","first-page":"16012","DOI":"10.1038\/npjamd.2016.12","volume":"2","author":"A Currais","year":"2016","unstructured":"Currais A, et\u00a0al. Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids. NPJ Aging Mech Dis. 2016;2:16012.","journal-title":"NPJ Aging Mech Dis"},{"issue":"16","key":"3457_CR38","doi-asserted-by":"publisher","first-page":"10819","DOI":"10.1073\/pnas.152334899","volume":"99","author":"TP Dinh","year":"2002","unstructured":"Dinh TP, et\u00a0al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA. 2002;99(16):10819\u201324.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"3457_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0009-3084(02)00150-0","volume":"121","author":"TP Dinh","year":"2002","unstructured":"Dinh TP, et\u00a0al. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. Chem Phys Lipids. 2002;121(1\u20132):149\u201358.","journal-title":"Chem Phys Lipids"},{"issue":"8","key":"3457_CR40","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","volume":"25","author":"BG Ram\u00edrez","year":"2005","unstructured":"Ram\u00edrez BG, et\u00a0al. Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci. 2005;25(8):1904\u201313.","journal-title":"J Neurosci"},{"issue":"2","key":"3457_CR41","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3233\/JAD-150913","volume":"51","author":"E Aso","year":"2016","unstructured":"Aso E, et\u00a0al. Cannabinoid receptor 2 participates in amyloid-\u03b2 processing in a mouse model of Alzheimer\u2019s disease but plays a minor role in the therapeutic properties of a cannabis-based medicine. J Alzheimer\u2019s Dis. 2016;51(2):489\u2013500.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"4","key":"3457_CR42","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3233\/JAD-130137","volume":"35","author":"E Aso","year":"2013","unstructured":"Aso E, et\u00a0al. CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in A\u03b2PP\/PS1 mice. J Alzheimer\u2019s Dis. 2013;35(4):847\u201358.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"3","key":"3457_CR43","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3233\/JAD-141014","volume":"43","author":"E Aso","year":"2015","unstructured":"Aso E, et\u00a0al. Cannabis-based medicine reduces multiple pathological processes in A\u03b2PP\/PS1 mice. J Alzheimer\u2019s Dis. 2015;43(3):977\u201391.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"2","key":"3457_CR44","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2125.2012.04341.x","volume":"75","author":"J Fern\u00e1ndez-Ruiz","year":"2013","unstructured":"Fern\u00e1ndez-Ruiz J, et\u00a0al. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? Br J Clin Pharmacol. 2013;75(2):323\u201333.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"3457_CR45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s12640-017-9806-x","volume":"33","author":"NA Suliman","year":"2018","unstructured":"Suliman NA, et\u00a0al. Delta-9-tetrahydrocannabinol (\u22069-THC) induce neurogenesis and improve cognitive performances of male Sprague Dawley rats. Neurotox Res. 2018;33(2):402\u201311.","journal-title":"Neurotox Res"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03457-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03457-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03457-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T09:16:36Z","timestamp":1657703796000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03457-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3457"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03457-w","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,12]]},"assertion":[{"value":"16 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This experimental treatment, involving a human participant, was reviewed and approved by the ethical committee of Unioeste University under number 2788021, Paran\u00e1, Brazil.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for this case report publication and any accompanying images. A copy of the written consent was available to the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared no actual or potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"277"}}